Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors

• Aditi S. Bapat,
• Christine H. O’Connor,
• Kathryn L. Schwertfeger

Affiliations

Aditi S. Bapat

Molecular Pharmacology and Therapeutics Graduate Program, University of Minnesota

Christine H. O’Connor

University of Minnesota Supercomputing Institute, University of Minnesota

Kathryn L. Schwertfeger

Molecular Pharmacology and Therapeutics Graduate Program, University of Minnesota